Author

Louis C. Kirby

Observed name: Louis Kirby

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Critical Path Institute, Diagnostics For All

OpenAlex ID: A5110125853

A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

2005 · on behalf of the Rofecoxib Protocol 078 study group, Leon J Thal, et al. · Neuropsychopharmacology · 408

Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies

2006 · Aaron I. Vinik, Michael Tuchman, et al. · Pain · 167

Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease

2009 · Carol Addy, Chris Assaid, et al. · The Journal of Clinical Pharmacology · 64

Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses

2004 · Chukwuemeka S. Okereke, Louis Kirby, et al. · British Journal of Clinical Pharmacology · 24

A multicenter clinical trial of gadolite oral suspension as a contrast agent for MRI

1997 · Daniel L. Rubin, Karen L. Falk, et al. · Journal of Magnetic Resonance Imaging · 24

Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study

2024 · Stewart J. Tepper, Detlef Albrecht, et al. · CNS Drugs · 7

O4-05-07 Neuropsychological, CSF, and neuropathological effects of A-beta immunotherapy (AN1792) of Alzheimer's disease in an interrupted trial

2004 · Sid Gilman, Martin Koller, et al. · Neurobiology of Aging · 6

P3‐383: The MARQ‐AD: A new measure of interview quality in Alzheimer's disease trials

2010 · Christopher J. Weber, Susan De Santi, et al. · Alzheimer s & Dementia · 1

P4‐236: The lympro® test: A biomarker for Alzheimer's disease using blood samples from clinically diagnosed Alzheimer's disease and cognitively intact subjects

2015 · Louis Kirby, Colin Bier, et al. · Alzheimer s & Dementia

P4‐181: The lympro® test: A fit for purpose validation of a flow cytometric assay to assess lymphocyte proliferation in peripheral blood lymphocytes in Alzheimer's disease

2015 · Paul Jorgensen, Louis Kirby, et al. · Alzheimer s & Dementia

P2‐071: Biomarker Qualification in Alzheimer's Disease

2011 · Holly Soares, Denise Frank, et al. · Alzheimer s & Dementia

F5‐03‐06: Biomarkers across other neurodegenerative diseases as Parkinson's disease (PD)

2011 · Louis Kirby · Alzheimer s & Dementia

P3‐349: Scale rating variability in Alzheimer's disease clinical trials: A literature review

2010 · Susan De Santi, Christopher J. Weber, et al. · Alzheimer s & Dementia

[P‐130]: Binding of the amyloid‐imaging PET tracer, Pittsburgh Compound‐B, to post‐mortem human brain tissue from the AN‐1792 immunotherapy trial

2005 · William E. Klunk, Milos D. Ikonomovic, et al. · Alzheimer s & Dementia

Works count: 14

Citation count: 701

H-index: 6

I10-index: 5